446 related articles for article (PubMed ID: 26502877)
21. Systemic inflammation after trauma.
Lenz A; Franklin GA; Cheadle WG
Injury; 2007 Dec; 38(12):1336-45. PubMed ID: 18048040
[TBL] [Abstract][Full Text] [Related]
22. Improvement of prognostic performance in severely injured patients by integrated clinico-transcriptomics: a translational approach.
Rittirsch D; Schoenborn V; Lindig S; Wanner E; Sprengel K; Günkel S; Schaarschmidt B; Märsmann S; Simmen HP; Cinelli P; Bauer M; Claus RA; Wanner GA
Crit Care; 2015 Nov; 19():414. PubMed ID: 26607226
[TBL] [Abstract][Full Text] [Related]
23. Development of metabolic and inflammatory mediator biomarker phenotyping for early diagnosis and triage of pediatric sepsis.
Mickiewicz B; Thompson GC; Blackwood J; Jenne CN; Winston BW; Vogel HJ; Joffe AR;
Crit Care; 2015 Sep; 19(1):320. PubMed ID: 26349677
[TBL] [Abstract][Full Text] [Related]
24. Intra-abdominal and pelvic emergencies.
Singh S; Khardori NM
Med Clin North Am; 2012 Nov; 96(6):1171-91. PubMed ID: 23102483
[TBL] [Abstract][Full Text] [Related]
25. Inflammatory mediators of cytokines and chemokines in sepsis: From bench to bedside.
Doganyigit Z; Eroglu E; Akyuz E
Hum Exp Toxicol; 2022; 41():9603271221078871. PubMed ID: 35337213
[No Abstract] [Full Text] [Related]
26. [Role of cytokines in sepsis and its current situation of clinical application].
Xia ZF; Wu GS
Zhonghua Shao Shang Za Zhi; 2019 Jan; 35(1):3-7. PubMed ID: 30678394
[TBL] [Abstract][Full Text] [Related]
27. Sepsis and the systemic inflammatory response syndrome.
Paterson RL; Webster NR
J R Coll Surg Edinb; 2000 Jun; 45(3):178-82. PubMed ID: 10881485
[TBL] [Abstract][Full Text] [Related]
28. Cerium oxide nanoparticles attenuate acute kidney injury induced by intra-abdominal infection in Sprague-Dawley rats.
Manne ND; Arvapalli R; Nepal N; Shokuhfar T; Rice KM; Asano S; Blough ER
J Nanobiotechnology; 2015 Oct; 13():75. PubMed ID: 26498824
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic efficacy and prognostic value of serum procalcitonin concentration in patients with suspected sepsis.
Ruiz-Alvarez MJ; García-Valdecasas S; De Pablo R; Sanchez García M; Coca C; Groeneveld TW; Roos A; Daha MR; Arribas I
J Intensive Care Med; 2009; 24(1):63-71. PubMed ID: 19054806
[TBL] [Abstract][Full Text] [Related]
30. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction.
Castelli GP; Pognani C; Meisner M; Stuani A; Bellomi D; Sgarbi L
Crit Care; 2004 Aug; 8(4):R234-42. PubMed ID: 15312223
[TBL] [Abstract][Full Text] [Related]
31. Source Identification and Source Control.
Oliver ZP; Perkins J
Emerg Med Clin North Am; 2017 Feb; 35(1):43-58. PubMed ID: 27908337
[TBL] [Abstract][Full Text] [Related]
32. Fatal Clostridium perfringens sepsis due to emphysematous gastritis and literature review.
Sarvari KP; Vasas B; Kiss I; Lazar A; Horvath I; Simon M; Peto Z; Urban E
Anaerobe; 2016 Aug; 40():31-4. PubMed ID: 27036998
[TBL] [Abstract][Full Text] [Related]
33. Multiplex cytokine analyses in dogs with pyometra suggest involvement of KC-like chemokine in canine bacterial sepsis.
Karlsson I; Hagman R; Johannisson A; Wang L; Södersten F; Wernersson S
Vet Immunol Immunopathol; 2016 Feb; 170():41-6. PubMed ID: 26837616
[TBL] [Abstract][Full Text] [Related]
34. Intra-abdominal Infections.
Napolitano LM
Semin Respir Crit Care Med; 2022 Feb; 43(1):10-27. PubMed ID: 35172355
[TBL] [Abstract][Full Text] [Related]
35. Cellular changes in association with defense mechanisms in intra-abdominal sepsis.
Pavlidis TE
Minerva Chir; 2003 Dec; 58(6):777-81. PubMed ID: 14663404
[TBL] [Abstract][Full Text] [Related]
36. A Molecular Host Response Assay to Discriminate Between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery and Validation in Independent Cohorts.
McHugh L; Seldon TA; Brandon RA; Kirk JT; Rapisarda A; Sutherland AJ; Presneill JJ; Venter DJ; Lipman J; Thomas MR; Klein Klouwenberg PM; van Vught L; Scicluna B; Bonten M; Cremer OL; Schultz MJ; van der Poll T; Yager TD; Brandon RB
PLoS Med; 2015 Dec; 12(12):e1001916. PubMed ID: 26645559
[TBL] [Abstract][Full Text] [Related]
37. Can one use biologic modifiers to prevent multiple organ dysfunction syndrome after abdominal infections?
Dellinger EP
Surg Infect (Larchmt); 2000; 1(3):239-47; discussion 247-8. PubMed ID: 12594894
[TBL] [Abstract][Full Text] [Related]
38. Current progress of source control in the management of intra-abdominal infections.
Wu XW; Zheng T; Hong ZW; Ren HJ; Wu L; Wang GF; Gu GS; Ren JA
Chin J Traumatol; 2020 Dec; 23(6):311-313. PubMed ID: 32863153
[TBL] [Abstract][Full Text] [Related]
39. Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury.
Kwon BK; Stammers AM; Belanger LM; Bernardo A; Chan D; Bishop CM; Slobogean GP; Zhang H; Umedaly H; Giffin M; Street J; Boyd MC; Paquette SJ; Fisher CG; Dvorak MF
J Neurotrauma; 2010 Apr; 27(4):669-82. PubMed ID: 20038240
[TBL] [Abstract][Full Text] [Related]
40. Sepsis and identification of reliable biomarkers for postoperative period prognosis.
Siloşi CA; Siloşi I; Pădureanu V; Bogdan M; Mogoantă SŞ; Ciurea ME; Cojocaru M; Boldeanu L; Avrămescu CS; Boldeanu MV; Popa DG
Rom J Morphol Embryol; 2018; 59(1):77-91. PubMed ID: 29940615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
